Latest Insider Transactions at Regeneron Pharmaceuticals, Inc. (REGN)
This section provides a real-time view of insider transactions for Regeneron Pharmaceuticals, Inc. (REGN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of REGENERON PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of REGENERON PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 14
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+20.46%
|
$295,000
$59.2 P/Share
|
|
Apr 14
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
5,497
-5.36%
|
$2,858,440
$520.68 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
7,582
-31.0%
|
$3,874,402
$511.56 P/Share
|
|
Apr 13
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
13,079
+34.84%
|
$680,108
$52.03 P/Share
|
|
Apr 13
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
828
-0.37%
|
$421,452
$509.95 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,672
-9.59%
|
$1,357,376
$508.25 P/Share
|
|
Apr 09
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,500
+11.16%
|
$952,000
$272.7 P/Share
|
|
Apr 07
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
696
-1.39%
|
$348,000
$500.15 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,304
-8.42%
|
$1,149,696
$499.95 P/Share
|
|
Apr 06
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.88%
|
$816,000
$272.7 P/Share
|
|
Apr 03
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
683
-0.28%
|
$337,402
$494.85 P/Share
|
|
Apr 02
2020
|
P Roy Vagelos Director |
SELL
Bona fide gift
|
Indirect |
433
-0.3%
|
-
|
|
Apr 02
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Open market or private sale
|
Direct |
6,797
-2.7%
|
$3,330,530
$490.97 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,353
-0.35%
|
$662,970
$490.51 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,317
-8.07%
|
$1,139,964
$492.05 P/Share
|
|
Apr 02
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+9.46%
|
$816,000
$272.7 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
1,200
-0.67%
|
$584,400
$487.35 P/Share
|
|
Apr 01
2020
|
Christopher R. Fenimore EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,200
+7.74%
|
$36,000
$30.63 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
SELL
Payment of exercise price or tax liability
|
Direct |
8,203
-12.71%
|
$4,003,064
$488.22 P/Share
|
|
Apr 01
2020
|
Joseph J Larosa EVP General Counsel and Secret |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+18.83%
|
$885,000
$59.2 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
4,647
-5.76%
|
$2,267,736
$488.21 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+6.9%
|
$1,632,000
$272.7 P/Share
|
|
Apr 01
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
600
-0.24%
|
$291,600
$486.54 P/Share
|
|
Apr 01
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.02%
|
$48,600
$486.06 P/Share
|
|
Mar 30
2020
|
Arthur F Ryan Director |
SELL
Open market or private sale
|
Direct |
100
-0.04%
|
$46,500
$465.94 P/Share
|
|
Mar 10
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Direct |
117,815
-0.81%
|
$55,726,495
$473.68 P/Share
|
|
Mar 09
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
128,921
-9.6%
|
$61,366,396
$476.42 P/Share
|
|
Mar 09
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
246,736
+15.48%
|
$7,402,080
$30.63 P/Share
|
|
Mar 09
2020
|
Joseph L Goldstein Director |
SELL
Open market or private sale
|
Direct |
2,000
-2.06%
|
$948,000
$474.28 P/Share
|
|
Mar 09
2020
|
Joseph L Goldstein Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+14.66%
|
$66,000
$33.42 P/Share
|
|
Mar 09
2020
|
Sanofi |
SELL
Open market or private sale
|
Direct |
128,914
-0.63%
|
$63,038,946
$489.65 P/Share
|
|
Feb 27
2020
|
Neil Stahl EVP Research and Development |
SELL
Open market or private sale
|
Direct |
10,349
-2.23%
|
$4,667,399
$451.97 P/Share
|
|
Feb 26
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Indirect |
2,400
-8.34%
|
$1,084,800
$452.83 P/Share
|
|
Feb 26
2020
|
George L Sing Director |
SELL
Open market or private sale
|
Direct |
2,500
-2.12%
|
$1,150,000
$460.0 P/Share
|
|
Feb 26
2020
|
George L Sing Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+2.08%
|
$82,500
$33.42 P/Share
|
|
Feb 26
2020
|
Neil Stahl EVP Research and Development |
SELL
Payment of exercise price or tax liability
|
Direct |
14,651
-40.27%
|
$6,607,601
$451.89 P/Share
|
|
Feb 26
2020
|
Neil Stahl EVP Research and Development |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+40.73%
|
$1,300,000
$52.03 P/Share
|
|
Feb 26
2020
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Open market or private sale
|
Direct |
15,642
-4.2%
|
$7,117,110
$455.99 P/Share
|
|
Feb 26
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
200
-0.1%
|
$91,000
$455.99 P/Share
|
|
Feb 26
2020
|
Neil Stahl EVP Research and Development |
SELL
Bona fide gift
|
Direct |
750
-3.45%
|
-
|
|
Feb 25
2020
|
Daniel P Van Plew EVP & General Mgr, Industrial |
SELL
Payment of exercise price or tax liability
|
Direct |
17,093
-28.03%
|
$7,640,571
$447.3 P/Share
|
|
Feb 25
2020
|
Daniel P Van Plew EVP & General Mgr, Industrial |
BUY
Exercise of conversion of derivative security
|
Direct |
32,735
+34.93%
|
$982,050
$30.63 P/Share
|
|
Feb 25
2020
|
Robert E Landry EVP Finance CFO |
SELL
Open market or private sale
|
Direct |
214
-0.08%
|
$95,872
$448.67 P/Share
|
|
Feb 25
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
800
-3.06%
|
$357,600
$447.3 P/Share
|
|
Feb 25
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.68%
|
$272,000
$272.7 P/Share
|
|
Feb 24
2020
|
Robert E Landry EVP Finance CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
786
-3.03%
|
$319,116
$406.59 P/Share
|
|
Feb 24
2020
|
Robert E Landry EVP Finance CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+3.71%
|
$272,000
$272.7 P/Share
|
|
Feb 24
2020
|
Michael S Brown Director |
SELL
Open market or private sale
|
Direct |
2,000
-40.21%
|
$838,000
$419.01 P/Share
|
|
Feb 24
2020
|
Michael S Brown Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+43.08%
|
$546,000
$273.67 P/Share
|
|
Feb 24
2020
|
George Yancopoulos Bd. Co-Chair, President & CSO |
SELL
Open market or private sale
|
Direct |
118,123
-18.58%
|
$49,611,660
$420.17 P/Share
|